| |
|


Gateway Global Partners
Announces New Investment and New Board Members
Gateway Global Partners Limited announces
that it has accepted further investment into the business and supplemented
its Board of Directors.
30th November 2005

Nujira names Mike McTighe
Chairman of the Board
Nujira Ltd, the Cambridge based company developing
advanced power amplifier technology for the wireless industry announced
today that it has appointed Mike McTighe as Chairman of the Board
of Directors.
3rd October 2005 
Antenova announces pentaband
RADIONOVA™ radio antenna modules
Antenova Ltd., the integrated RF solutions
company, today announced the availability of Pentaband RADIONOVA™
radio antenna modules, the first production ready integrated radio
antenna module offering design flexibility, cost reduction and time
to market advantages.
27th September 2005

Intercytex expands Executive
Management team
Intercytex, the cell therapy company developing
products for the advanced woundcare and aesthetic medicine markets,
today announces the appointment of John St Clair Roberts MRCS, LRCP,
FFPM, as Vice President Medical Affairs.
6th September 2005

DanioLabs announces appointment
of CEO Pharmaceutical entrepreneur
Tony Sedgwick to lead DanioLabs' therapeutics and service divisions’
evolution. 5th September 2005

Cambridge
Gateway Fund Opens Up New Opportunities With Management Buyout
Cambridge Gateway Fund, the early stage technology
Venture Management Fund, is breaking new ground with a management
buyout from the NW Brown Group.
6th July 2005

DanioLabs Announce the Appointment
of Dr David Chiswell as Non-
Executive Chairman
DanioLabs Ltd (Cambridge, UK), announced today
the appointment of Dr David Chiswell as non-executive Chairman. Dr
Chiswell replaces Dr Roger Brimblecombe who has retired from the DanioLabs
Board. The Board wish to thank Dr Brimblecombe for all his help and
guidance which he has given the company since its beginnings in 2002.
4th April 2005

Cambridge Gateway Fund announces
sale of drug discovery company Cambridge Biotechnology Limited to
Biovitrum
It has been announced today that Biovitrium
has agreed to acquire Cambridge Biotechnology Ltd (“CBT”).
Through this move, Biovitrum is developing its therapeutic area base,
advancing and balancing the medical and commercial potential of the
product portfolio, expanding the technology platform and strengthening
its position as a leading European player.
22nd March 2005

Antenova Names Nigel Litchfield
as New Chairman of the Board
Antenova Ltd, the integrated RF solutions
company, announced today that it has appointed Nigel Litchfield as
Chairman of the Board, replacing former chairman Dr Peter Radley.
Nokia veteran and former President of Vertu, Litchfield brings with
him a strong history of product innovation and international market
development to support Antenova’s global strategy.
2nd March 2005

Antenova Launches RADIONOVA
Radio Antenna Modules
Antenova Ltd., the integrated RF solutions
company, today launched RADIONOVA, a range of fully integrated radio
antenna modules that significantly reduce the cost and complexity
of adding wireless connectivity to mobile phones, laptop PCs and other
consumer electronic devices.
4th February 2005

Cambridge Gateway Fund makes further
investment in CacheLogic Limited
The Cambridge Gateway Fund has invested a
further £700,000 as part of a £3 million equity investment
into CacheLogic Limited.
20th January 2005

Cambridge Gateway Fund makes
further investment in Antenova Limited, the integrated RF solutions
company
The Cambridge Gateway Fund has made a further
investment of £0.6 million, as part of a £6.3 million
funding round in Antenova Limited.
20th January 2005

Cambridge
Gateway Fund invests in disease modelling company DanioLabs Limited
The Cambridge Gateway Fund has led a £3.2M
equity funding round in Cambridge-based DanioLabs Limited, an international
leader in high content biological systems screening.
17th January 2005

Intercytex Announces Appointment
Of Chief Executive Officer
Intercytex Limited, an emerging healthcare
company developing products for the treatment of chronic wounds and
hair loss, announces the appointment of Nick Higgins
as Chief Executive Officer with immediate effect.
10th January 2005 
|
|
 |